statistics in vBulletin
  1. This site is not associated with any agent or consultant and colleges/universities. Views & Opinions expressed here are solely author's comment and is not responsible for them. Please don't make derogatory or abusive remarks against anyone.
  2. Prepare for GMAT, CAT, IIT, PMT & Other Entrance Exams. Post your questions and get answers. Collaborate, Learn & Grow.
    Dismiss Notice
  3. Hi Please download our Android App and enjoy the benefit of this forum on your smartphone. Download in Playstore
    Dismiss Notice
  4. Find Best Colleges in your Area, review them and share feedback.
    Dismiss Notice

Global Single-Use Bioreactors Market by 2030

Discussion in 'Business Analysis' started by Stella Wilson, Jun 30, 2021.

  1. Stella Wilson

    Stella Wilson New Member

    Single-use bioreactors are a revolutionary product of the process optimization efforts of drug manufacturers, offering a highly flexible approach to rapidly produce multiple drugs, while notably reducing downtime between batches and operational costs


    Roots Analysis has announced the addition of “Single-Use Bioreactors Market, 2021-2030” report to its list of offerings.

    Traditionally, stainless steel bioreactors were the preferred choice for production of biologics; however, over the past couple of decades, biopharmaceutical manufacturing has gradually witnessed a shift towards the use of single-use technologies. Apart from low contamination risk and better product yield, single-use bioreactors are easy-to-install and have a much smaller footprint, compared to the traditional stainless steel systems.

    Get Detailed Report:

    Key Market Insights

    160 single-use bioreactors are currently available / under development for different scales of operation

    It is worth noting that most of the single-use bioreactors (49%) are stirred tank bioreactors, followed by pneumatically mixed bioreactors (9%). It is worth highlighting that nearly 70% of single-use bioreactors support laboratory scale operations.

    Majority (40%) of the single-use bioreactors are intended for mammalian cell culture

    Presently, several bioreactors are also being used to culture appropriate host cells for studying the pathogenesis of the novel coronavirus. Other popular application areas for single-use bioreactors include stem cell research (47%), and cancer research (20%).

    Close to 40 players are driving the activity within the single-use bioreactors industry

    Majority (47%) of the initiatives in this domain are led by small-sized firms, followed by mid-sized (24%) and large players (29%). Further, around 60% of the firms engaged in providing single-use bioreactors were established post 2000.

    Partnership activity in this field has grown at a CAGR of ~16%, between 2015 and 2020

    Nearly 45% of the reported deals were established after 2015, with the maximum activity being reported in 2017. Majority of the partnerships inked within this domain were product / technology integration agreements (30%), followed by full business acquisitions (22%) and product / technology development agreements (15%).

    2,800+ patents that have been filed / granted for single-use bioreactors, till 2020

    Based on the intellectual property distribution across the world, R&D activity related to single-use bioreactors is largely concentrated in the US (around 47%). Majority of the patents in this field were filed by industry players (94%).

    North America and Europe are anticipated to capture over 33.5% of the market share by 2030

    The market in Asia-Pacific are anticipated to grow at a relatively faster rate (over 20%). In 2030, mammalian cell cultures are likely to capture the largest market share (36%) in terms of revenues from product sales, followed by viral cell cultures (20%), microbial cell cultures (15%) and insect cell cultures (11%).

    Request for Customization:

    Key Questions Answered

    · Who are the leading manufacturers engaged in the development of single-use bioreactors?

    · What are the different applications of single-use bioreactors?

    · Which partnership models are commonly adopted by stakeholders in this industry?

    · Which features of single-use bioreactors are most important to end-users?

    · What are the challenges currently faced by stakeholders in this industry?

    · What are the key factors that are likely to influence the evolution of this market?

    · How has the COVID-19 pandemic impacted the single-use bioreactors market?

    · How is the current and future opportunity likely to be distributed across key market segments?

    · What are the anticipated future trends related to single-use bioreactors?

    The USD 6.6 billion (by 2030) financial opportunity within the single-use bioreactors market has been analysed across the following segments:

    Type of Cell Culture

    · Bacterial Cell Cultures

    · Insect Cell Cultures

    · Mammalian Cell Cultures

    · Microbial Cell Cultures

    · Plant Cell Cultures

    · Viral Cell Cultures

    · Other Cell Cultures

    Type of Molecule

    · Cell Therapies

    · Gene Therapies

    · Monoclonal Antibodies

    · Recombinant Proteins

    · Stem Cell Therapies

    · Vaccines

    · Other Molecules

    Application Area

    · Cancer Research

    · Drug Discovery and Toxicity Testing

    · Regenerative Medicine and Tissue Engineering

    · Stem Cell Research

    · Other Application Areas

    Scale of Operation

    · Small Scale Operations

    · Large Scale Operations


    · Research and Development

    · Biopharmaceutical Manufacturing


    · Biopharmaceutical / Pharmaceutical Industries

    · Academic / Research Institutes

    Key Geographical Regions

    · North America

    · Europe

    · Asia-Pacific

    · Latin America (LATM)

    · Middle East and North Africa (MENA)

    · Rest of the World (RoW)

    The report features inputs from eminent industry stakeholders, according to whom, the US is likely to dominate this market, despite the fact that the country is currently facing several political challenges, as well as problems related to the COVID-19 pandemic. The report includes detailed transcripts of discussions held with the following industry experts:

    · Per Stobbe (Chief Executive Officer, Marketing, Technical Support, CerCell)

    · Torsten Due Bryld (Chief Commercial Officer, CelVivo)

    Request for PDF Sample:

    The research includes detailed profiles of key players (listed below) engaged in the development of single-use bioreactors; each profile features an overview of the developer, details related to its product portfolio, and recent developments, and an informed future outlook:

    · Celartia

    · Cell Culture Company

    · Cellexus

    · CerCell

    · CESCO Bioengineering

    · Cytiva

    · Eppendorf

    · Merck Millipore

    · Pall Corporation

    · PBS Biotech

    · PerfuseCell

    · Pierre Guerin

    · ProlifeCell

    · Sartorius Stedim Biotech

    · Solaris Biotech

    · Synthecon

    · Thermo Fisher Scientific

    Also have a Look on Our Upcoming Research Reports

    Soft Tissue Sarcoma: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031

    Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market Trends and Global Forecasts, 2021-2030

    Spinal Muscular Atrophy Market, 2021-2031

    Dravet Syndrome Market, 2021-2031

    Hypertrophic Cardiomyopathy Market 2021-2031

Share This Page